Herrera, F. G., Bourhis, J. & Coukos, G. Radiotherapy mixture alternatives leveraging immunity for the subsequent oncology follow. CA Most cancers J. Clin. 67, 65–85 (2017).
Google Scholar
Demaria, S., Golden, E. B. & Formenti, S. C. Function of native radiation remedy in most cancers immunotherapy. JAMA Oncol. 1, 1325–1332 (2015).
Google Scholar
McLaughlin, M. et al. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat. Rev. Most cancers 20, 203–217 (2020).
Google Scholar
Barker, H. E., Paget, J. T., Khan, A. A. & Harrington, Ok. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Most cancers 15, 409–425 (2015).
Google Scholar
Merad, M. & Salmon, H. Most cancers: a dendritic-cell brake on antitumour immunity. Nature 523, 294–295 (2015).
Google Scholar
Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1–10 (2013).
Google Scholar
Tang, M. et al. Toll-like receptor 2 activation promotes tumor dendritic cell dysfunction by regulating IL-6 and IL-10 receptor signaling. Cell Rep. 13, 2851–2864 (2015).
Google Scholar
Saxena, M., van der Burg, S. H., Melief, C. J. & Bhardwaj, N. Therapeutic most cancers vaccines. Nat. Rev. Most cancers 21, 360–378 (2021).
Google Scholar
Wculek, S. Ok. et al. Dendritic cells in most cancers immunology and immunotherapy. Nat. Rev. Immunol. 20, 7–24 (2020).
Google Scholar
Broz, M. L. et al. Dissecting the tumor myeloid compartment reveals uncommon activating antigen-presenting cells crucial for T cell immunity. Most cancers Cell 26, 638–652 (2014).
Google Scholar
Min, Y. et al. Antigen-capturing nanoparticles enhance the abscopal impact and most cancers immunotherapy. Nat. Nanotechnol. 12, 877–882 (2017).
Google Scholar
Wang, W. et al. Systemic immune responses to irradiated tumours by way of the transport of antigens to the tumour periphery by injected flagellate micro organism. Nat. Biomed. Eng. 6, 44–53 (2022).
Google Scholar
Teitz-Tennenbaum, S. et al. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Most cancers Res. 63, 8466–8475 (2003).
Google Scholar
Choi, C. W. et al. Mixture remedy of stereotactic physique radiation remedy and immature dendritic cell vaccination for augmentation of native and systemic results. Most cancers. Res. Deal with. 51, 464–473 (2019).
Google Scholar
Baharom, F. et al. Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment. Cell. 185, 4317–4332.e15 (2022).
Google Scholar
Giles, J. R. et al. CD8 T cells within the cancer-immunity cycle. Immunity 56, 2231–2253 (2023).
Google Scholar
Verdijk, P. et al. Restricted quantities of dendritic cells migrate into the T cell space of lymph nodes however have excessive immune activating potential in melanoma sufferers. Clin. Most cancers Res. 15, 2531–2540 (2009).
Google Scholar
Buzas, E. I. The roles of extracellular vesicles within the immune system. Nat. Rev. Immunol. 23, 236–250 (2023).
Google Scholar
Ding, X. et al. Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes. Nat. Nanotechnol. 20, 156–166 (2024).
Google Scholar
Liu, G. et al. Micro organism-derived nanovesicles improve tumour vaccination by skilled immunity. Nat. Nanotechnol. 19, 387–398 (2024).
Google Scholar
Kalluri, R. & LeBleu, V. S. The biology, perform, and biomedical purposes of exosomes. Science 367, eaau6977 (2020).
Google Scholar
Marar, C., Starich, B. & Wirtz, D. Extracellular vesicles in immunomodulation and tumor development. Nat. Immunol. 22, 560–570 (2021).
Google Scholar
Vader, P., Mol, E. A., Pasterkamp, G. & Schiffelers, R. M. Extracellular vesicles for drug supply. Adv. Drug Deliv. Rev. 106, 148–156 (2016).
Google Scholar
Wiklander, O. P. B. et al. Antibody-displaying extracellular vesicles for focused most cancers remedy. Nat. Biomed. Eng. 8, 1453–1468 (2024).
Yue, Y. et al. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered micro organism. Nat. Biomed. Eng. 6, 898–909 (2022).
Google Scholar
Ruhland, M. Ok. et al. Visualizing synaptic switch of tumor antigens amongst dendritic cells. Most cancers Cell 37, 786–799.e5 (2020).
Google Scholar
Pitt, J. M. et al. Dendritic cell-derived exosomes for most cancers remedy. J. Clin. Make investments. 126, 1224–1232 (2016).
Google Scholar
Pitt, J. M. et al. Dendritic cell-derived exosomes as immunotherapies within the struggle towards most cancers. J. Immunol. 193, 1006–1011 (2014).
Google Scholar
Mu, N. et al. Plant-derived exosome-like nanovesicles: present progress and prospects. Int. J. Nanomed. 18, 4987–5009 (2023).
Google Scholar
Lian, M. Q. et al. Plant-derived extracellular vesicles: latest developments and present challenges on their use for biomedical purposes. J. Extracell. Vesicles 11, e12283 (2022).
Google Scholar
Wong, A. S., Che, C. M. & Leung, Ok. W. Latest advances in ginseng as most cancers therapeutics: a useful and mechanistic overview. Nat. Prod. Rep. 32, 256–272 (2015).
Google Scholar
Liu, S. et al. Structural characterization of a novel polysaccharide from Panax notoginseng residue and its immunomodulatory exercise on bone marrow dendritic cells. Int. J. Biol. Macromol. 161, 797–809 (2020).
Google Scholar
Kang, S. & Min, H. Ginseng, the ‘immunity enhance’: the consequences of panax ginseng on immune system. J. Ginseng Res. 6, 354–368 (2012).
Google Scholar
Krawczyk, Ok. et al. Electrogenetic mobile insulin launch for real-time glycemic management in kind 1 diabetic mice. Science 368, 993–1001 (2020).
Google Scholar
Hao, Y. et al. Promotion or inhibition of extracellular vesicle launch: rising therapeutic alternatives. J. Management. Launch 340, 136–148 (2021).
Google Scholar
Mayer, A. Intracellular membrane fusion: SNAREs solely?. Curr. Opin. Cell Biol. 11, 447–452 (1999).
Google Scholar
Bennaceur, Ok. et al. Dendritic cells dysfunction in tumour surroundings. Most cancers Lett. 272, 186–196 (2008).
Google Scholar
Feng, J. et al. Plant-derived vesicle-like nanoparticles as promising biotherapeutic instruments: current and future. Adv. Mater. 35, e2207826 (2023).
Google Scholar
Li, Q. et al. The mix of gemcitabine and ginsenoside Rh2 enhances the immune perform of dendritic cells towards pancreatic most cancers by way of the CARD9-BCL10-MALT1/NF-κB pathway. Clin Immunol. 248, 109217 (2023).
Google Scholar
Son, Ok. J., Choi, Ok. R., Lee, S. J. & Lee, H. Immunogenic cell loss of life induced by ginsenoside Rg3: significance in dendritic cell-based anti-tumor immunotherapy. Immune Netw. 16, 75–84 (2016).
Google Scholar
Zhang, Y. et al. Useful regulation of ginsenosides on myeloid immunosuppressive cells within the tumor microenvironment. Integr. Most cancers Ther. 18, 1534735419886655 (2019).
Google Scholar
Kalluri, R. The biology and performance of exosomes in most cancers. J. Clin. Make investments. 126, 1208–1215 (2016).
Google Scholar
Mathieu, M., Martin-Jaular, L., Lavieu, G. & Théry, C. Specificities of secretion and uptake of exosomes and different extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 21, 9–17 (2019).
Google Scholar
Savina, A., Furlán, M., Vida, L. M. & Colombo, M. I. Exosome launch is regulated by a calcium-dependent mechanism in K562 cells. J. Biol. Chem. 278, 20083–20090 (2003).
Google Scholar
Messenger, S. W., Woo, S. S., Solar, Z. & Martin, T. F. J. A Ca2+-stimulated exosome launch pathway in most cancers cells is regulated by Munc13-4. J. Cell Biol. 217, 2877–2890 (2018).
Google Scholar
MacNabb, B. W. et al. Dendritic cells can prime anti-tumor CD8+ T cell responses by way of main histocompatibility advanced cross-dressing. Immunity 55, 2206–2208 (2022).
Google Scholar
Pittet, M. J., Di Pilato, M., Garris, C. & Mempel, T. R. Dendritic cells as shepherds of T cell immunity in most cancers. Immunity 56, 2218–2230 (2023).
Google Scholar
Reis e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476–483 (2006).
Google Scholar
Moon, C. Y. et al. Dendritic cell maturation in most cancers. Nat. Rev. Most cancers 25, 225–248 (2025).
Google Scholar
Carrillo-Conde, B. et al. Mannose-functionalized ‘pathogen-like’ polyanhydride nanoparticles goal C-type lectin receptors on dendritic cells. Mol. Pharm. 8, 1877–1886 (2011).
Google Scholar
Tomura, M. et al. Monitoring and quantification of dendritic cell migration and antigen trafficking between the pores and skin and lymph nodes. Sci. Rep. 4, 6030 (2014).
Google Scholar
Moriya, T. et al. Immunogenic tumor cell loss of life promotes dendritic cell migration and inhibits tumor progress by way of enhanced T cell immunity. iScience 24, 102424 (2021).
Google Scholar
Shand, F. H. et al. Monitoring of intertissue migration reveals the origins of tumor-infiltrating monocytes. Proc. Natl Acad. Sci. USA 111, 7771–7776 (2014).
Google Scholar
Manno, M., Bongiovanni, A., Margolis, L., Bergese, P. & Arosio, P. The physico-chemical panorama of extracellular vesicles. Nat. Rev. Bioeng. 3, 68–82 (2025).
Google Scholar
Wang, S. et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci. Transl. Med. 13, eabb6981 (2021).
Google Scholar
Qin, H. et al. Growth of a most cancers vaccine utilizing in vivo click-chemistry-mediated lively lymph node accumulation for improved immunotherapy. Adv. Mater. 33, e2006007 (2021).
Google Scholar
Li, N. et al. Potent prophylactic most cancers vaccines harnessing floor antigens shared by tumour cells and induced pluripotent stem cells. Nat. Biomed. Eng. 9, 215–233 (2025).
Google Scholar
Gong, N. et al. Enhancing in situ most cancers vaccines utilizing supply applied sciences. Nat. Rev. Drug Discov. 23, 607–625 (2024).
Google Scholar
![[2606.16533] Kairos: A Native World Mannequin Stack for Bodily AI](http://arxiv.org/static/browse/0.3.4/images/arxiv-logo-fb.png "[2606.16533] Kairos: A Native World Mannequin Stack for Bodily AI"){kind=logo}
